FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mike Bunce

Research Profile

Procedures

Genes & Molecular Sequences

Chemicals & Drugs

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Michael Worobey; Marlea Gemmel; Dirk E Teuwen; Tamara Haselkorn; Kevin Kunstman; Mike Bunce; Jean-Jacques Muyembe; Jean-Marie M Kabongo; Raphaël M Kalengayi; Eric Van Marck; M Thomas P Gilbert; Steven M Wolinsky
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960.
Peter A Horn; M Albis-Camps; M Verboom; Mike Bunce; K Yousaf; S Williams; Rainer Blasczyk
The nature of diversity of HLA-DRB1 exon 3.
M H Sheldon; MP Azzaro; D Sayer; Mike Bunce; G Sortino
Identification of a new allele in a Sicilian individual: HLA-DPB1*0302.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mike Bunce (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Michael Worobey; Marlea Gemmel; Dirk E Teuwen; Tamara Haselkorn; Kevin Kunstman; Mike Bunce; Jean-Jacques Muyembe; Jean-Marie M Kabongo; Raphaël M Kalengayi; Eric Van Marck; M Thomas P Gilbert; Steven M Wolinsky
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960.
Nature 2008;455(7213):661-4.
2007: Peter A Horn; M Albis-Camps; M Verboom; Mike Bunce; K Yousaf; S Williams; Rainer Blasczyk
The nature of diversity of HLA-DRB1 exon 3.
Tissue antigens 2007;70(4):335-7.
2005: M H Sheldon; MP Azzaro; D Sayer; Mike Bunce; G Sortino
Identification of a new allele in a Sicilian individual: HLA-DPB1*0302.
Tissue antigens 2005;66(1):64-6.
2004: Photini Kiepiela; Alasdair Leslie; Isobella Honeyborne; Danni Ramduth; Christina Thobakgale; Senica Chetty; Prinisha Rathnavalu; Corey Moore; Katja Pfafferott; Louise Hilton; Peter Zimbwa; Sarah Moore; Todd Allen; Christian Brander; Marylyn M Addo; Marcus Altfeld; Ian James; Simon Mallal; Mike Bunce; Linda D Barber; James Szinger; Cheryl Day; Paul Klenerman; James Mullins; Bette Korber; Hoosen M Coovadia; Bruce D Walker; Philip J R Goulder
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
Nature 2004;432(7018):769-75.
2004: Kathryn Maitland; Mike Bunce; Rosalind M Harding; M C N M Barnardo; John B Clegg; K Welsh; DK Bowden; Thomas N Williams
HLA class-I and class-II allele frequencies and two-locus haplotypes in Melanesians of Vanuatu and New Caledonia.
Tissue antigens 2004;64(6):678-86.
2004: Margarete A Fabre; Des C Jones; Mike Bunce; Peter J Morris; Peter J Friend; Ken I Welsh; Sara E Marshall
The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2004;17(9):531-9.
2004: G V Testa; Mike Bunce; M H Sheldon; P P J Dunn; S Day; S B D Marques
Identification of a new allele, HLA-DRB1*1360, on a DRB5 haplotype in a Brazilian individual.
Tissue antigens 2004;63(6):617-8.
2004: Samantha Winsey; Lorne Lonie; Jill Allen; Mike Bunce; Sara E Marshall; Fenella Wojnarowska
Genetic variation in COL17A1 and the development of bullous pemphigoid.
Experimental dermatology 2004;13(3):140-7.
2003: Des C Jones; Mike Bunce; S V Fuggle; Neil T Young; Sara E Marshall
Human platelet alloantigens (HPAs): PCR-SSP genotyping of a UK population for 15 HPA alleles.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2003;30(6):415-9.
2003: Tariq Ahmad; Alessandro Armuzzi; Matt J Neville; Mike Bunce; Khoon-Lin Ling; Ken I Welsh; Sara E Marshall; Derek P Jewell
The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis.
Tissue antigens 2003;62(6):527-35.
2003: H P Marsh; Neil A Haldar; Mike Bunce; Sara E Marshall; K le Monier; Samantha Winsey; K Christodoulos; D Cranston; Ken I Welsh; Adrian L Harris
Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation.
British journal of cancer 2003;89(6):1096-101.
2003: Natalie S Shenker; Neil A Haldar; John-Joe Reilly; Mike Bunce; Ken I Welsh; Sara E Marshall
The impact of endothelial nitric oxide synthase polymorphisms on long-term renal allograft outcome.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(6):391-5.
2003: Tariq Ahmad; Matt J Neville; Sara E Marshall; Alessandro Armuzzi; Kim Mulcahy-Hawes; Jonathan Crawshaw; Hiroe Sato; Khoon-Lin Ling; M C N M Barnardo; Sue Goldthorpe; Robert Walton; Mike Bunce; Derek P Jewell; Ken I Welsh
Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC.
Human molecular genetics 2003;12(6):647-56.
2003: Tariq Ahmad; Graham R Wallace; Teifi James; Matt J Neville; Mike Bunce; Kim Mulcahy-Hawes; Alessandro Armuzzi; Jonathan Crawshaw; Farida Fortune; Robert Walton; Miles R Stanford; Ken I Welsh; Sara E Marshall; Derek P Jewell
Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?
Arthritis and rheumatism 2003;48(3):807-13.
2003: Colin M Gelder; O Martin Williams; Keith W Hart; Siôn Wall; Gareth Williams; Duncan Ingrams; Peter Bull; Mike Bunce; Ken Welsh; Sara E Marshall; Leszek K Borysiewicz
HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis.
Journal of virology 2003;77(3):1927-39.
2003: Mike Bunce
PCR-sequence-specific primer typing of HLA class I and class II alleles.
Methods in molecular biology (Clifton, N.J.) 2003;210():143-71.
2002: D C Jones; Neil T Young; C Pigott; Susan V Fuggle; M C N M Barnardo; Sara E Marshall; Mike Bunce
Comprehensive hereditary hemochromatosis genotyping.
Tissue antigens 2002;60(6):481-8.
2002: Alison Levoguer; Aviva D Witkover; Alun L Lloyd; Katie J M Jeffery; Asna Siddiqui; Sara E Marshall; Mike Bunce; Nobutaka Eiraku; Shuji Izumo; Koichiro Usuku; Mitsuhiro Osame; Charles R M Bangham
Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
The Journal of infectious diseases 2002;186(7):932-9.
2002: Tariq Ahmad; Sara E Marshall; Kim Mulcahy-Hawes; T Orchard; Jonathan Crawshaw; Alessandro Armuzzi; Matt J Neville; David A van Heel; M C N M Barnardo; Ken I Welsh; Derek P Jewell; Mike Bunce
High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility.
Tissue antigens 2002;60(2):164-79.
2002: M H Sheldon; Mike Bunce; P P J Dunn; S Day; G D Lee; Y-J Park; B K Bang; B K Kim; E-J Oh
Identification of two new alleles in a single Korean individual, HLA-B*1568 and HLA-DRB1*1208.
Tissue antigens 2002;59(5):430-2.
2002: M L Davies; Stephen Young; K Welsh; Mike Bunce; B P Wordsworth; K A Davies; D R Wagenknecht; E Taylor; Caroline Gordon; Shirley Jobson; David Briggs; Simon J Bowman
Immune responses to native beta(2)-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Rheumatology (Oxford, England) 2002;41(4):395-400.
2002: Tariq Ahmad; Alessandro Armuzzi; Mike Bunce; Kim Mulcahy-Hawes; Sara E Marshall; Timothy R Orchard; Jonathan Crawshaw; Oliver Large; Arjuna de Silva; Julia T Cook; M C N M Barnardo; Sue Cullen; Ken I Welsh; Derek P Jewell
The molecular classification of the clinical manifestations of Crohn's disease.
Gastroenterology 2002;122(4):854-66.
2002: Andreas C Papassavas; M C N M Barnardo; Mike Bunce; Ken I Welsh
Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
Transplantation 2002;73(4):642-51.
2002: Marie L Davies; Emma J Taylor; Caroline Gordon; Stephen Young; Ken Welsh; Mike Bunce; B Paul Wordsworth; Brian Davidson; Simon J Bowman
Candidate T cell epitopes of the human La/SSB autoantigen.
Arthritis and rheumatism 2002;46(1):209-14.
2001: Constantin Ionescu-Tîrgoviste; Cristian Guja; MH Herr; E Cucca; K Welsh; Mike Bunce; S Marshall; John A Todd
Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of Type I diabetes.
Diabetologia 2001;44 Suppl 3():B60-6.
2001: Penny J Hunt; SE Marshall; Anthony P Weetman; Mike Bunce; JI Bell; J A H Wass; Ken I Welsh
Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease.
Clinical endocrinology 2001;55(4):491-9.
2001: Philip J R Goulder; Christian Brander; Yanhua Tang; C Tremblay; Robert A Colbert; Marylyn M Addo; Eric S Rosenberg; T Nguyen; R Allen; Alicja Trocha; Marcus Altfeld; S He; Mike Bunce; Robert Funkhouser; Stephen I Pelton; Sandra K Burchett; Kenneth McIntosh; Bette T Korber; Bruce D Walker
Evolution and transmission of stable CTL escape mutations in HIV infection.
Nature 2001;412(6844):334-8.
2001: D C Jones; Colin M Gelder; T Ahmad; IA Campbell; M C N M Barnardo; Ken I Welsh; Sara E Marshall; Mike Bunce
CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease.
Tissue antigens 2001;58(1):19-23.
2001: Gillian Harcourt; Simon Hellier; Mike Bunce; Jack Satsangi; J Collier; R Chapman; Rodney Phillips; Paul Klenerman
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection.
Journal of viral hepatitis 2001;8(3):174-9.
2001: Philip J R Goulder; Marylyn M Addo; Marcus Altfeld; Eric S Rosenberg; Yanhua Tang; UG Govender; N Mngqundaniso; K Annamalai; T U Vogel; M Hammond; Mike Bunce; Hoosen M Coovadia; Bruce D Walker
Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays.
Journal of virology 2001;75(3):1339-47.
2001: Philip J R Goulder; Marcus Altfeld; Eric S Rosenberg; T Nguyen; Yanhua Tang; Robert L Eldridge; Marylyn M Addo; S He; Joia S Mukherjee; Mary N Phillips; Mike Bunce; Spyros A Kalams; Rafick-Pierre Sekaly; Bruce D Walker; Christian Brander
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.
The Journal of experimental medicine 2001;193(2):181-94.
2000: Katie J M Jeffery; A A Siddiqui; Mike Bunce; Alun L Lloyd; Alison Levoguer; Aviva D Witkover; Shuji Izumo; Koichiro Usuku; Kenneth I Welsh; Mitsuhiro Osame; Charles R M Bangham
The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(12):7278-84.
2000: E Mallon; Mike Bunce; H Savoie; Anthony Rowe; Roger B Newson; F Gotch; Christopher B Bunker
HLA-C and guttate psoriasis.
The British journal of dermatology 2000;143(6):1177-82.
2000: Sara E Marshall; A J McLaren; Neil A Haldar; Mike Bunce; Peter J Morris; Ken I Welsh
The impact of recipient cytokine genotype on acute rejection after renal transplantation.
Transplantation 2000;70(10):1485-91.
2000: A P Williams; S Bevan; Mike Bunce; R Houlston; K I Welsh; Tim Elliott
Identification of novel Tapasin polymorphisms and linkage disequilibrium to MHC class I alleles.
Immunogenetics 2000;52(1-2):9-11.
2000: A Henderson; Mike Bunce; N Siddon; Raymond Reeves; David J Tremethick
High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter.
Journal of virology 2000;74(22):10523-34.
2000: Samantha Winsey; Neil A Haldar; H P Marsh; Mike Bunce; Sara E Marshall; Adrian L Harris; Fenella Wojnarowska; Ken I Welsh
A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer.
Cancer research 2000;60(20):5612-6.
2000: Martin Petrek; Jiri Drabek; Vitezslav Kolek; J Zlámal; K I Welsh; Mike Bunce; Evzen Weigl; Roland M Du Bois
CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis.
American journal of respiratory and critical care medicine 2000;162(3 Pt 1):1000-3.
2000: M C N M Barnardo; AW Harmer; O J Shaw; G S Ogg; Mike Bunce; Robert W Vaughan; peter morris; Ken I Welsh
Detection of HLA-specific IGG antibodies using single recombinant HLA alleles: the MonoLISA assay.
Transplantation 2000;70(3):531-6.
2000: J T Cook; S Day; P P J Dunn; Ken I Welsh; Mike Bunce
Identification of a new HLA-B*39 allele: HLA-B*3924.
Tissue antigens 2000;56(2):178-9.
2000: P Krausa; C Münz; W Keilholz; S Stevanovic; E Yvonne Jones; M Browning; Mike Bunce; H G Rammensee; Andrew McMichael
Definition of peptide binding motifs amongst the HLA-A*30 allelic group.
Tissue antigens 2000;56(1):10-8.
2000: Philip J R Goulder; Christian Brander; K Annamalai; N Mngqundaniso; UG Govender; Yanhua Tang; S He; Kelly Hartman; Christopher A O'Callaghan; GS Ogg; Marcus Altfeld; Eric S Rosenberg; H Cao; Spyros A Kalams; M Hammond; Mike Bunce; Stephen I Pelton; S A Burchett; Kenneth McIntosh; Hoosen M Coovadia; Bruce D Walker
Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
Journal of virology 2000;74(12):5679-90.
2000: Mike Bunce; J Procter; P P J Dunn; S Day; J Ross; Ken I Welsh
Identification of the null HLA-A2 allele, A*0232N.
Tissue antigens 2000;55(1):31-6.
1999: Charles G Mullighan; Sara E Marshall; Mike Bunce; K I Welsh
Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency.
Genes and immunity 1999;1(2):137-48.
1999: M Janer; A Cowland; J Picard; D Campbell; P Pontarotti; John Newsom-Davis; Mike Bunce; K Welsh; A Demaine; A G Wilson; Nick Willcox
A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C.
Human immunology 1999;60(9):909-17.
1999: AS Carter; Lucia Cerundolo; Mike Bunce; Dicken D H Koo; Ken I Welsh; Peter J Morris; Susan V Fuggle
Nested polymerase chain reaction with sequence-specific primers typing for HLA-A, -B, and -C alleles: detection of microchimerism in DR-matched individuals.
Blood 1999;94(4):1471-7.
1999: Jiri Drabek; Mike Bunce; Ingrid Faé; Z Ambruzová; P Dunn; J Ross; Gottfried F Fischer
Characterization of a novel HLA-A*24 allele containing an HLA-A*03 sequence motif.
Tissue antigens 1999;54(1):98-101.
1999: Mike Bunce; J Procter; Ken I Welsh
A DNA-based detection and screening system for identifying HLA class I expression variants by sequence-specific primers.
Tissue antigens 1999;53(5):498-506.
1999: Katie J M Jeffery; Koichiro Usuku; SE Hall; Wataru Matsumoto; Graham P Taylor; J Procter; Mike Bunce; G S Ogg; Kenneth I Welsh; Jonathan N Weber; Alun L Lloyd; Martin A Nowak; Masahiro Nagai; Daisuke Kodama; Shuji Izumo; Mitsuhiro Osame; Charles R M Bangham
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(7):3848-53.
1999: Susan Tonks; SG Marsh; Mike Bunce; JG Bodmer
Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop.
Tissue antigens 1999;53(2):175-83.
1999: K Welsh; Mike Bunce
Molecular typing for the MHC with PCR-SSP.
Reviews in immunogenetics 1999;1(2):157-76.
1999: P Krausa; S McAdam; Mike Bunce; Jimmy Whitworth; Benon Biryahwaho; French Neil; B Tugume; Charles Gilks; F Gotch
HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 polymorphism detected by PCR-SSP in a semi-urban HIV-positive Ugandan population.
Experimental and clinical immunogenetics 1999;16(1):17-25.
1998: I Scott; J O'Shea; Mike Bunce; J M Tiercy; J Rafael Argüello; H Firman; J Goldman; H Grant Prentice; Ann-Margaret Little; J Alejandro Madrigal
Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection.
Blood 1998;92(12):4864-71.
1998: Mike Bunce; M C N M Barnardo; K I Welsh
The PCR-SSP Manager computer program: a tool for maintaining sequence alignments and automatically updating the specificities of PCR-SSP primers and primer mixes.
Tissue antigens 1998;52(2):158-74.
1998: AS Carter; Mike Bunce; Lucia Cerundolo; Ken I Welsh; Peter J Morris; Susan V Fuggle
Detection of microchimerism after allogeneic blood transfusion using nested polymerase chain reaction amplification with sequence-specific primers (PCR-SSP): a cautionary tale.
Blood 1998;92(2):683-9.
1998: MJ Herrero; Mike Bunce; M van Dam; Rosario de Pablo; Carlos Vilches
On the nature of "HLA-B42" alloantibodies. Specific reagents for HLA-Cw*17?
Tissue antigens 1998;52(1):92-5.
1998: Charles G Mullighan; Mike Bunce; GC Fanning; Sara E Marshall; KI Welsh
A rapid method of haplotyping HFE mutations and linkage disequilibrium in a Caucasoid population.
Gut 1998;42(4):566-9.
1998: M C N M Barnardo; Ken I Welsh; C Vilches; Kathryn Maitland; Mike Bunce
Allele-specific HLA-B*15 typing by PCR-SSP and its application to four distinct ethnic populations.
Tissue antigens 1998;51(3):293-300.
1998: Carlos Vilches; Mike Bunce; M van Dam; Rosario de Pablo
A new pair of HLA-C alleles, Cw*12042 and Cw*1203, differing at the KIR-related dimorphism of codons 77-80.
Tissue antigens 1998;51(1):101-5.
1998: FC Gilchrist; Mike Bunce; Penny Lympany; Kenneth I Welsh; Roland M Du Bois
Comprehensive HLA-DP typing using polymerase chain reaction with sequence-specific primers and 95 sequence-specific primer mixes.
Tissue antigens 1998;51(1):51-61.
1997: Mike Bunce; Neil T Young; Ken I Welsh
Molecular HLA typing--the brave new world.
Transplantation 1997;64(11):1505-13.
1997: Charles G Mullighan; Mike Bunce; Ken I Welsh
High-resolution HLA-DQB1 typing using the polymerase chain reaction and sequence-specific primers.
Tissue antigens 1997;50(6):688-92.
1997: Philip J R Goulder; Mike Bunce; Graz Luzzi; Rodney E Phillips; A J McMichael
Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses.
AIDS (London, England) 1997;11(15):1884-6.
1997: J Procter; J Crawford; Mike Bunce; Ken I Welsh
A rapid molecular method (polymerase chain reaction with sequence-specific primers) to genotype for ABO blood group and secretor status and its potential for organ transplants.
Tissue antigens 1997;50(5):475-83.
1997: MD Strettell; LJ Thomson; Peter T Donaldson; Mike Bunce; C M O'Neill; Roger Williams
HLA-C genes and susceptibility to type 1 autoimmune hepatitis.
Hepatology (Baltimore, Md.) 1997;26(4):1023-6.
1997: E Mallon; Mike Bunce; Fenella Wojnarowska; K Welsh
HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics.
The Journal of investigative dermatology 1997;109(2):183-6.
1997: Mike Bunce; M C N M Barnardo; J Procter; S G Marsh; C Vilches; Ken I Welsh
High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology.
Tissue antigens 1997;50(1):100-11.
1997: Carlos Vilches; Mike Bunce; Rosario de Pablo; Anna K Murray; CA McIntyre; M Kreisler
Complete coding regions of two novel HLA-B alleles detected by phototyping (PCR-SSP) in the British caucasoid population: B*5108 and B*5002.
Tissue antigens 1997;50(1):38-41.
1997: GC Fanning; Mike Bunce; C M Black; KI Welsh
Polymerase chain reaction haplotyping using 3' mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha.
Tissue antigens 1997;50(1):23-31.
1997: Carlos Vilches; Mike Bunce; Rosario de Pablo; ME Moreno; Sabino Puente; L Sanz; M Kreisler
The novel HLA-Cw*1802 allele is associated with B*5703 in the Bubi population from Equatorial Guinea.
Tissue antigens 1997;49(6):644-8.
1997: M C N M Barnardo; Mike Bunce; christopher Lord; Ken I Welsh
HLA-B*5603: sequence of a novel hybrid allele comprising B*56 and B*4601 segments.
Tissue antigens 1997;49(5):496-8.
1997: R Spencer Wells; Mark Seielstad; Mike Bunce; Dolly Tyan; E Bekele; Peter Parham
Cw*1701 defines a divergent african HLA-C allelic lineage.
Immunogenetics 1997;46(3):173-80.
1997: Neil T Young; Mike Bunce; Peter J Morris; Ken I Welsh
Killer cell inhibitory receptor interactions with HLA class I molecules: implications for alloreactivity and transplantation.
Human immunology 1997;52(1):1-11.
1996: Philip J R Goulder; Mike Bunce; P Krausa; K McIntyre; S Crowley; B Morgan; Anne Edwards; P L F Giangrande; Rodney E Phillips; Andrew J McMichael
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.
AIDS research and human retroviruses 1996;12(18):1691-8.
1996: Carlos Vilches; Mike Bunce; L Sanz; Rosario de Pablo; Sabino Puente; M Kreisler
Molecular cloning of two new HLA-C alleles: Cw*1801 and Cw*0706.
Tissue antigens 1996;48(6):698-702.
1996: Mike Bunce; M C N M Barnardo; J Procter; S G Marsh; Carlos Vilches; K I Welsh
High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology.
Tissue antigens 1996;48(6):680-91.
1996: M Brown; Mike Bunce; A Calin; C Darke; P Wordsworth
HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al.
Arthritis and rheumatism 1996;39(10):1768-9.
1996: Martin D Curran; F Williams; J A Earle; B K Rima; M G van Dam; Mike Bunce; DEREK MIDDLETON
Long-range PCR amplification as an alternative strategy for characterizing novel HLA-B alleles.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1996;23(4):297-309.
1996: M C N M Barnardo; N J Davey; Mike Bunce; Paul A Brookes; Robert I Lechler; K I Welsh; J R Batchelor
A correlation between HLA-C matching and donor antirecipient CTL precursor frequency in bone marrow transplantation.
Transplantation 1996;61(9):1420-3.
1996: Jack Satsangi; K I Welsh; Mike Bunce; C Julier; J M Farrant; John I Bell; D P Jewell
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Lancet 1996;347(9010):1212-7.
1996: L Sanz; Carlos Vilches; Rosario de Pablo; Mike Bunce; ME Moreno; M Kreisler
Haplotypic association of two new HLA class I alleles: Cw*15052 and B*0706: evolutionary relationships of HLA-Cw*15 alleles.
Tissue antigens 1996;47(4):329-32.
1996: C M O'Neill; Mike Bunce; K I Welsh
Detection of the DRB4 null gene, DRB4*0101102N, by PCR-SSP and its distinction from other DRB4 genes.
Tissue antigens 1996;47(3):245-8.
1995: Mike Bunce; C M O'Neill; M C N M Barnardo; P Krausa; M J Browning; Peter J Morris; K I Welsh
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).
Tissue antigens 1995;46(5):355-67.
1995: Carlos Vilches; Mike Bunce; Rosario de Pablo; M J Herrero; M Kreisler
Anchored PCR cloning of the novel HLA-Cw*0704 allele detected by PCR-SSP.
Tissue antigens 1995;46(1):19-23.
1995: P Krausa; M Brywka; D Savage; Kam M Hui; Mike Bunce; J L Ngai; D L Teo; Y W Ong; D Barouch; C E Allsop
Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations.
Tissue antigens 1995;45(4):223-31.
1995: P Marren; J Yell; F M Charnock; Mike Bunce; K Welsh; Fenella Wojnarowska
The association between lichen sclerosus and antigens of the HLA system.
The British journal of dermatology 1995;132(2):197-203.
1995: Mike Bunce; GC Fanning; K I Welsh
Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP).
Tissue antigens 1995;45(2):81-90.